Gilead Sciences remains a bullish pick, with raised guidance and strong Q3/25 results, driving optimism for continued growth.

Ares Dynamic Credit Allocation Fund (ARDC) receives a Sell rating due to its heavy allocation to floating rate issuances amid ...

Alphabet ( GOOG) ( GOOGL) shares popped in premarket trading Tuesday, putting the technology conglomerate on track to reach ...

The Global X Uranium ETF (URA) has retraced 50% of its recent rally, presenting a potential buying opportunity amid strong ...

Taiwan Semiconductor Manufacturing ( TSM) filed a lawsuit against its former senior vice president for corporate strategy ...

Discover why PennantPark Investment (PNNT) faces a downgrade amid falling earnings, unsustainable dividends, and risk of a ...

Asset portfolios provided solid absolute returns for the quarter but fell short of blended benchmarks on a relative basis.

B2Gold is actively taking steps to reduce its dependence on Mali, with Goose Mine in Canada ramping up. Read why I rate BTG ...

Implied volatilities were mixed across major asset classes last week as traders jostled to reprice risk assets amidst ...

The Virtus Duff & Phelps Water Fund slightly underperformed the S&P Global Water Index in the third quarter. The ...

Frontline plc (FRO) remains a buy but is now best suited for aggressive investors due to a lower yield and higher valuation.

iHuman (IH) offers educational apps and devices, trading at a deep discount to global peers and below its cash value, ...